Activity value 75china Buyer&Supplier,Last transaction date:
2026-06-27
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for dijia pharmaceutical group co ltd from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 32 transactions, with a transaction quantity of 26289.4 and a transaction weight of 50.4.
YearTransactionsQuantityWeight
202589113635.99196.2
20263226289.450.4
Bill of lading data
<
1/15
>
Trade date
2026/06/27
B/L No.
——
Suppliers
dijia pharmaceutical group co ltd
Buyers
semos pharamaceuticals pvt ltd.
POLs
——
PODs
kape
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
6024.300611
Hs code
29359090
Product tags
t 12,bat,pharmaceutical raw material,celecoxib usp,r pharm
Product description
CELECOXIB USP (Pharmaceutical Raw Material for Pharmaceutical Industry), Batch # CE260119 Mfg dt 22-01-2026 Exp dt 12-2028.
Expand
Trade date
2026/06/24
B/L No.
108371000730
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty tnhh alpha trade
Product description
PHARMACEUTICAL ALLOPATHIC RAW MATERIAL (FLAVOXATE HCL )......BATCH NO FH260308F -- FH260309F .......MFG DATE 30/03/2026....31/03/2026......EXP DATE 01/02/2028....31/03/N2G0U2z8D.9.z.a.4.Z.VNSEGT WEIGHT 200 KG
Expand
Trade date
2026/06/01
B/L No.
——
Suppliers
dijia pharmaceutical group co ltd
Buyers
crystolite pharamaceuticals
Product description
Dược chất Rivaroxaban, dạng bột, dùng để nghiên cứu thuốc dạng viên nén bao phim, tiêu chuẩn Ph.Eur.12.1, số lô: RV250705A, NSX: 10/07/2025, Retest: 06/2028, Mới 100%
Expand
Trade date
2026/05/07
B/L No.
108216293510
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty cổ phần dược phẩm adlers
Product description
Dược chất Rivaroxaban, dạng bột, dùng để nghiên cứu thuốc dạng viên nén bao phim, tiêu chuẩn Ph.Eur.12.1, số lô: RV241201A, NSX: 06/12/2024, Retest: 11/2027, Mới 100%
Expand
Trade date
2026/04/27
B/L No.
——
Suppliers
dijia pharmaceutical group co ltd
Buyers
chem expertz limited
POLs
——
PODs
dhaka
Supply area
China
Purchas area
Bangladesh
Weight
0.4kg
Amount
5
Hs code
29335990
Product tags
white powde,flunarizine dihydrochloride
Product description
FLUNARIZINE DIHYDROCHLORIDE WHITE POWDER SAMPLE
Expand
Trade date
2026/04/23
B/L No.
108182466230
Suppliers
dijia pharmaceutical group co ltd
Buyers
công ty cổ phần dược phẩm tv pharm
5honour lab ltd.
indiabuyer,they trade on 2026-02-15
83.43%
>
+View All
Products
Total 54
ProductsTransactionsPerDetail
methyl 5154.84%>
propy 5154.84%>
benzimidazole 5053.76%>
methylbenzimidazole 3436.56%>
benz 1516.13%>
+View All
Hscode rank
Total 16
HSCode NameTransactionsPerDetail
HS 293399902931.18%>
HS 293329902223.66%>
HS 2934999099.68%>
HS 2933599088.6%>
HS 2918300088.6%>
+View All
Trading Area
Total 6
AreaTransactionsPerDetail
india9842.06%>
pakistan6628.33%>
vietnam4318.45%>
bangladesh156.44%>
turkey62.58%>
+View All
Port statistics
Total 2
Port NameTransactionsPerDetail
qingdao20.86%>
shanghai10.43%>
dijia pharmaceutical group co ltd is china Buyer&Supplier,
and primarily engages in the import and export business of products such as methyl,propy,benzimidazole.
According to the 52wmb.com global trade database, as of 2026-06-27, the company has completed 233 international trades,
with its main trading regions covering india,pakistan,vietnam etc.
The core products include HS29339990,HS29332990,HS29349990 etc,
often transported via qingdao,port shanghai etc,
and its main trading partners are dhanuka laboratories ltd.,verdant life sciences pvt ltd.,sharika life science ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on dijia pharmaceutical group co ltd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.